|
|
|
40
|
1201P
|
AZARGA 1% | 0.5% EYE DR (NVS/COL) BRINZOLAMIDE |
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
C
|
19.79
|
19.79
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
1201P
|
AZARGA 1%|0.5% EYE DR (NVS) BRINZOLAMIDE|TIMOLOL (BQ)
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
BQ
|
19.79
|
19.7894
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
1201P
|
AZARGA 1%|0.5% EYE DR (NVS) BRINZOLAMIDE|TIMOLOL
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
BQ
|
19.79
|
19.79
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A371E
|
BRIZOTEN 1% EYE DR (LPO/COL) BRINZOLAMIDE
|
BRINZOLAMIDE
|
BRIZOTEN
|
5ML
|
A
|
19.03
|
19.03
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
42
|
A371E
|
BRIZOTEN 1% EYE DR (LPO) BRINZOLAMIDE
|
BRINZOLAMIDE
|
BRIZOTEN
|
5ML
|
C
|
24.46
|
24.46
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
41
|
A371R
|
AZOPT 1% EYE DR (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
10ML
|
A
|
29.22
|
29.222
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2024-06-17
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
|
|
|
41
|
A371V
|
AZOPT 1% DROPS (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
5ML BOTT
|
A
|
14.61
|
14.61
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
|
|
|
42
|
A371V
|
AZOPT 1% EYE DR (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
5ML
|
A
|
14.62
|
14.62
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|